Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 2:31 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 531335 | NSE: ZYDUSWELL

Zydus Wellness Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹498.80Undervalued by 14.40%vs CMP ₹436.00

P/E (57.7) × ROE (6.0%) × BV (₹179.00) × DY (0.28%)

₹228.42Overvalued by 47.61%vs CMP ₹436.00
MoS: -90.9% (Negative)Confidence: 56/100 (Moderate)Models: 1 Fair, 6 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹460.4730%Fair (+5.6%)
Graham NumberEarnings₹161.9222%Over (-62.9%)
Net Asset ValueAssets₹179.3410%Over (-58.9%)
EV/EBITDAEnterprise₹58.2712%Over (-86.6%)
Earnings YieldEarnings₹65.1010%Over (-85.1%)
ROCE CapitalReturns₹153.5110%Over (-64.8%)
Revenue MultipleRevenue₹127.727%Over (-70.7%)
Consensus (7 models)₹228.42100%Overvalued
Key Drivers: Wide model spread (₹58–₹460) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -7.7%

*Investments are subject to market risks

Investment Snapshot

53
Zydus Wellness Ltd scores 53/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health58/100 · Moderate
ROCE 6.2% WeakROE 6.0% AverageD/E 0.12 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money40/100 · Moderate
FII holding stable No changeDII holding down 1.18% MF sellingPromoter holding at 69.6% Stable
Earnings Quality50/100 · Moderate
OPM stable around 14% Steady
Quarterly Momentum60/100 · Moderate
Revenue (4Q): +31% YoY AcceleratingProfit (4Q): -36% YoY Declining
Industry Rank45/100 · Moderate
P/E 57.7 vs industry 112.3 Cheaper than peersROCE 6.2% vs industry 16.4% Below peersROE 6.0% vs industry 17.5% Below peers3Y sales CAGR: 10% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:31 am

Market Cap 13,872 Cr.
Current Price 436
Intrinsic Value₹228.42
High / Low 531/317
Stock P/E57.7
Book Value 179
Dividend Yield0.28 %
ROCE6.16 %
ROE6.02 %
Face Value 2.00
PEG Ratio-7.51

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Zydus Wellness Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Zydus Wellness Ltd 13,872 Cr. 436 531/31757.7 1790.28 %6.16 %6.02 % 2.00
Bikaji Foods International Ltd 15,582 Cr. 621 821/59259.7 61.40.16 %20.1 %16.0 % 1.00
Hindustan Foods Ltd 5,892 Cr. 494 609/42243.2 87.10.00 %14.3 %14.0 % 2.00
Mrs Bectors Food Specialities Ltd 5,797 Cr. 189 355/17441.5 39.60.64 %18.1 %15.6 % 2.00
Parag Milk Foods Ltd 2,408 Cr. 193 377/15418.0 96.20.52 %14.1 %12.3 % 10.0
Industry Average19,776.38 Cr581.69112.2889.800.31%16.37%17.51%5.63

All Competitor Stocks of Zydus Wellness Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 416713702440403783841493462913861650965
Expenses 388568586423390620686473447723705628904
Operating Profit 28145116171316215520151901562361
OPM % 7%20%17%4%3%21%18%4%3%21%18%4%6%
Other Income 1-6-12434510413-33-6
Interest 455666413421641
Depreciation 67666655513112556
Profit before tax 1912693941541522410173145-51-42
Tax % -1%-15%-18%31%92%3%3%12%37%1%12%4%-4%
Net Profit 2014511060150148216172128-53-40
EPS in Rs 0.624.573.470.190.014.724.640.660.205.404.02-1.66-1.25

Last Updated: February 6, 2026, 10:47 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 18, 2026, 1:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 4044313974315138431,7671,8672,0092,2552,3282,7093,389
Expenses 3193313053313876581,4461,5221,6641,9182,0202,3292,960
Operating Profit 851009199125185321344345337308380430
OPM % 21%23%23%23%24%22%18%18%17%15%13%14%13%
Other Income 192832323528-33-12310-5-019-35
Interest 0001230140842616241264
Depreciation 0877913262524252428105
Profit before tax 104120117124150171121112306291260359227
Tax % 5%7%10%10%9%-0%-17%-6%-1%-7%-3%3%
Net Profit 98111105111137171142119309310267347207
EPS in Rs 4.945.585.285.586.855.874.923.739.719.758.3910.906.51
Dividend Payout % 24%22%25%23%23%17%20%27%10%10%12%11%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)13.27%-5.41%5.71%23.42%24.82%-16.96%-16.20%159.66%0.32%-13.87%29.96%
Change in YoY Net Profit Growth (%)0.00%-18.67%11.12%17.71%1.39%-41.78%0.76%175.86%-159.34%-14.19%43.83%

Zydus Wellness Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:20%
5 Years:9%
3 Years:10%
TTM:11%
Compounded Profit Growth
10 Years:12%
5 Years:13%
3 Years:2%
TTM:6%
Stock Price CAGR
10 Years:12%
5 Years:9%
3 Years:14%
1 Year:7%
Return on Equity
10 Years:7%
5 Years:6%
3 Years:6%
Last Year:6%

Last Updated: September 4, 2025, 9:45 pm

Balance Sheet

Last Updated: December 4, 2025, 12:52 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 39393939395858646464646464
Reserves 2863674395186523,3293,4034,5044,7805,0595,2945,6085,642
Borrowings 00025251,5691,5195503872973291883,042
Other Liabilities 99102891001125036105484614134625821,134
Total Liabilities 4255085686828295,4595,5905,6665,6925,8336,1486,4429,882
Fixed Assets 9584821031044,5674,6744,6674,7104,7324,7085,1258,446
CWIP 0000010441213101513
Investments 5094301484611002770783628
Other Assets 3244233915505778358029959431,0181,3541,2661,394
Total Assets 4255085686828295,4595,5905,6665,6925,8336,1486,4429,882

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 916990776914925928723792246380
Cash from Investing Activity + 1329-28-72-59-4,092-17-10-59-85-178-207
Cash from Financing Activity + -27-27-58-6-24,052-260-216-234-138-26-186
Net Cash Flow 77714-18109-1860-56-13243-13
Free Cash Flow 867286466113223526916247220315
CFO/OP 116%80%114%86%64%115%81%83%70%28%81%99%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow85.00100.0091.0074.00100.00184.00320.00-206.00-42.0040.00-21.00192.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 2133642241826344449
Inventory Days 1087673127113393168158135146150148
Days Payable 191146191264254662289189136100116122
Cash Conversion Cycle -82-69-116-134-135-227-97-1325807875
Working Capital Days -48-37-38-57-26-26-7-35-27172034
ROCE %35%32%26%23%22%7%6%6%6%6%5%6%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 66.45%67.11%68.54%69.15%69.62%69.62%69.62%69.62%69.64%69.64%69.64%69.64%
FIIs 3.87%3.23%3.42%3.25%3.26%3.29%3.36%3.37%3.29%3.25%3.43%3.27%
DIIs 22.18%22.04%20.22%19.67%19.41%19.44%20.37%20.12%19.76%19.27%18.76%18.58%
Public 7.51%7.62%7.81%7.91%7.71%7.65%6.67%6.89%7.30%7.83%8.18%8.51%
No. of Shareholders 70,79073,02976,59075,36969,13863,97360,98164,03764,97966,51477,18880,105

Shareholding Pattern Chart

No. of Shareholders

Zydus Wellness Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Parag Parikh Flexi Cap Fund 22,000,000 0.74 986.26N/AN/AN/A
Nippon India Small Cap Fund 17,048,030 1.16 764.2616,848,0302026-01-25 02:17:241.19%
Quant Small Cap Fund 9,033,845 1.48 404.99N/AN/AN/A
Quant Multi Cap Fund 1,676,074 1.01 75.141,250,0002026-01-25 06:16:3934.09%
Nippon India Consumption Fund 1,358,672 2.42 60.911,403,0002025-12-15 00:28:01-3.16%
Quant Manufacturing Fund 1,180,010 8.31 52.9N/AN/AN/A
Parag Parikh ELSS Tax Saver Fund 1,135,555 0.88 50.91N/AN/AN/A
Quant Healthcare Fund 641,730 8.45 28.77N/AN/AN/A
Baroda BNP Paribas Small Cap Fund 408,400 1.57 18.31N/AN/AN/A
Quant Consumption Fund 368,669 8.4 16.53460,7232026-02-23 05:55:52-19.98%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 37.0041.9448.7848.5419.55
Diluted EPS (Rs.) 37.0041.9448.7848.5419.55
Cash EPS (Rs.) 59.0145.7152.7152.2522.61
Book Value[Excl.RevalReserv]/Share (Rs.) 891.76842.37805.07761.28717.87
Book Value[Incl.RevalReserv]/Share (Rs.) 891.76842.37805.07761.28717.87
Revenue From Operations / Share (Rs.) 425.93366.01354.36315.75293.36
PBDIT / Share (Rs.) 61.8450.6453.7555.8155.52
PBIT / Share (Rs.) 57.3746.9049.8252.1051.57
PBT / Share (Rs.) 56.4140.9045.7148.0917.63
Net Profit / Share (Rs.) 54.5441.9748.7848.5418.66
NP After MI And SOA / Share (Rs.) 54.5441.9748.7848.5418.66
PBDIT Margin (%) 14.5113.8315.1617.6718.92
PBIT Margin (%) 13.4712.8114.0516.5017.57
PBT Margin (%) 13.2411.1712.8915.236.01
Net Profit Margin (%) 12.8011.4613.7615.376.36
NP After MI And SOA Margin (%) 12.8011.4613.7615.376.36
Return on Networth / Equity (%) 6.114.986.056.372.59
Return on Capital Employeed (%) 6.405.546.166.736.70
Return On Assets (%) 5.384.345.325.422.09
Long Term Debt / Equity (X) 0.000.000.000.010.06
Total Debt / Equity (X) 0.030.060.050.070.12
Asset Turnover Ratio (%) 0.430.380.050.040.02
Current Ratio (X) 1.481.621.311.061.10
Quick Ratio (X) 0.781.020.650.580.62
Inventory Turnover Ratio (X) 5.502.240.890.780.54
Dividend Payout Ratio (NP) (%) 9.1611.9110.2510.300.00
Dividend Payout Ratio (CP) (%) 8.4710.939.489.570.00
Earning Retention Ratio (%) 90.8488.0989.7589.700.00
Cash Earning Retention Ratio (%) 91.5389.0790.5290.430.00
Interest Coverage Ratio (X) 32.7713.4221.2713.924.22
Interest Coverage Ratio (Post Tax) (X) 29.4212.7120.9313.113.99
Enterprise Value (Cr.) 10742.169439.4210116.339760.9712849.96
EV / Net Operating Revenue (X) 3.974.054.494.866.88
EV / EBITDA (X) 27.3129.3129.5827.4836.37
MarketCap / Net Operating Revenue (X) 3.924.024.374.756.72
Retention Ratios (%) 90.8388.0889.7489.690.00
Price / BV (X) 1.871.751.931.972.75
Price / Net Operating Revenue (X) 3.924.024.374.756.72
EarningsYield 0.030.020.030.030.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Zydus Wellness Ltd. is a Public Limited Listed company incorporated on 01/11/1994 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L15201GJ1994PLC023490 and registration number is 023490. Currently Company is involved in the business activities of Manufacture of other dairy products. Company's Total Operating Revenue is Rs. 292.60 Cr. and Equity Capital is Rs. 63.60 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Food Processing - Bakery/Dairy/Fruits/OthersZydus Corporate Park, Ahmedabad Gujarat 382481Contact not found
Management
NamePosition Held
Dr. Sharvil P PatelChairman
Mr. Tarun G AroraWholeTime Director & CEO
Mr. Ganesh N NayakNon Executive Director
Mr. Kulin S LalbhaiIndependent Director
Mr. Akhil A MonappaIndependent Director
Mr. Srivishnu Raju NandyalaIndependent Director
Ms. Dharmishtaben N RavalIndependent Woman Director

FAQ

What is the intrinsic value of Zydus Wellness Ltd and is it undervalued?

As of 12 April 2026, Zydus Wellness Ltd's intrinsic value is ₹228.42, which is 47.61% lower than the current market price of ₹436.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (6.02 %), book value (₹179), dividend yield (0.28 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Zydus Wellness Ltd?

Zydus Wellness Ltd is trading at ₹436.00 as of 12 April 2026, with a FY2026-2027 high of ₹531 and low of ₹317. The stock is currently in the middle of its 52-week range. Market cap stands at ₹13,872 Cr..

How does Zydus Wellness Ltd's P/E ratio compare to its industry?

Zydus Wellness Ltd has a P/E ratio of 57.7, which is below the industry average of 112.28. This is broadly in line with or below the industry average.

Is Zydus Wellness Ltd financially healthy?

Key indicators for Zydus Wellness Ltd: ROCE of 6.16 % is on the lower side compared to the industry average of 16.37%; ROE of 6.02 % is below ideal levels (industry average: 17.51%). Dividend yield is 0.28 %.

Is Zydus Wellness Ltd profitable and how is the profit trend?

Zydus Wellness Ltd reported a net profit of ₹347 Cr in Mar 2025 on revenue of ₹2,709 Cr. Compared to ₹309 Cr in Mar 2022, the net profit shows an improving trend.

Does Zydus Wellness Ltd pay dividends?

Zydus Wellness Ltd has a dividend yield of 0.28 % at the current price of ₹436.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Zydus Wellness Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports